Reported Aug 14, 2024 · Terminated
Gabapentin Tablets, USP, 600 mg, 500-count bottles, Rx only, Manufactured by: Granules India Limited Hyderabad-500 081,…
Granules Pharmaceuticals Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Granules Pharmaceuticals Inc. · 3701 Concorde Pkwy · Chantilly, VA · 20151-1126
Is this the product you have?
- Gabapentin Tablets, USP, 600 mg, 500-count bottles, Rx only
- Manufactured byGranules India Limited Hyderabad-500 081, India
- Manufactured forGranules Pharmaceuticals Inc., Chantilly, VA NDC 70010-227-05
- Lot codes and dates
Lot 1380040AExp. date July 312025
- Amount recalled
- 11,808 500-count Bottles
Where it was sold
- Nationwide
Why it was recalled
Presence of Foreign Tablets; 3 fused tablets of Metformin ER 500 mg were found in bottle of Gabapentin Tablets
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Granules Pharmaceuticals Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.